ANDROGRAPHOLIDE DERIVATIVES FOR USE IN THE TREATMENT OF COVID-19 DISEASE AND PULMONARY FIBROSIS ASSOCIATED WITH COVID-19

Patent number:

No items found.

Disclosed are andrographolide derivatives for use as an antiviral agent in the treatment of COVID-19 disease or pulmonary fibrosis associated with COVID-19.

Countries:

Spain

Regions:

Valencian Community

Navarre

Centers:

CSIC, UNIVERSITAT DE VALENCIA, FUNDACION PARA LA INVESTIG MEDICA APLICADA, UNIVERSIDAD PUBLICA DE NAVARRA, UNIVERSITAT POLITECNICA DE VALENCIA, FUNDACION PARA LA INVESTIGACION MEDICA APLICADA, UNIVERSIDAD DE NAVARRA

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

Comments

Other related patents

Health

Thoracic vest and associated device for respiratory therapy.

Countries

Spain

Health

PROCEDURE TO DETERMINE THE EFFICACY OF THE TREATMENT AND THE DEGREE OF PROGRESSION OF THE CHRONIC LEUKEMIA THROUGH THE USE OF SPI-1/PU.1

Countries

Spain

Health

Chemicals

Food & Agro

COMPOSITION FOR THE REDUCTION OF METABOLIC DECLIVE ASSOCIATED WITH AGING AND/OR THE TREATMENT OF DISORDERS RELATED TO LIPID METABOLISM (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries

Spain

Get back to patents directory